The importance of standardized treatment in high-grade osteosarcoma: 30 years of experience from a hospital-based database

References

• Damron TA, Ward WG, Stewart A. Osteosarcoma, chondrosarcoma, and Ewing’s sarcoma: National cancer data base report. Clin Orthop Relat Res 2007;459:40–7.
   PubMed Web of Science ®Google Scholar
• Link MP, Goorin AM, Miser AW, Green AA, Pratt CB, Belasco JB, et al. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med 1986;314:1600–6.
   PubMed Web of Science ®Google Scholar
• Souhami RL, Craft AW, Van der Eijken JW, Nooij M, Spooner D, Bramwell VH, et al. Randomised trial of two regimens of chemotherapy in operable osteosarcoma: A study of the European Osteosarcoma Intergroup. Lancet 1997;350:911–7.
   PubMed Web of Science ®Google Scholar
• Sampo M, Koivikko M, Taskinen M, Kallio P, Kivioja A, Tarkkanen M, et al. Incidence, epidemiology and treatment results of osteosarcoma in Finland – a nationwide population-based study. Acta Oncol 2011;50:1206–14.
   PubMed Web of Science ®Google Scholar
• Kim MS, Lee SY, Cho WH, Song WS, Koh JS, Lee JA, et al. Initial tumor size predicts histologic response and survival in localized osteosarcoma patients. J Surg Oncol 2008;97: 456–61.
   PubMed Web of Science ®Google Scholar
• Massimo B, Giovanni G, Stefano F, Eleonora B, Adalberto Bdel P, Sandra A, et al. Phase 2 trial of two courses of cyclophosphamide and etoposide for relapsed high-risk osteosarcoma patients. Cancer 2009;115:2980–7.
   PubMed Web of Science ®Google Scholar
• Kager L, Zoubek A, Potschger U, Kastner U, Flege S, Kempf-Bielack B, et al. Primary metastatic osteosarcoma: Presentation and outcome of patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 2003;21:2011–8.
   PubMed Web of Science ®Google Scholar
• Petrilli AS, de Camargo B, Filho VO, Bruniera P, Brunetto AL, Jesus-Garcia R, et al. Results of the Brazilian Osteosarcoma Treatment Group Studies III and IV: Prognostic factors and impact on survival. J Clin Oncol 2006;24: 1161–8.
   PubMed Web of Science ®Google Scholar
• Statistic denmark, population denmark [Internet]. 2013. Available from: http://www.statistikbanken.dk [cited 2013 Dec 1].
   Google Scholar
• Maretty-Nielsen K, Aggerholm-Pedersen N, Keller J, Safwat A, Baerentzen S, Pedersen AB. Population-based aarhus sarcoma registry: Validity, completeness of registration, and incidence of bone and soft tissue sarcomas in western Denmark. Clin Epidemiol 2013;5:45–56.
   PubMedGoogle Scholar
• Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res 1980;(153):106–20.
   PubMed Web of Science ®Google Scholar
• The Danish Civil Registry, Danish Act on the Civil Registration System [Internet]. 2013. Available from: http://cpr.dk.
   Google Scholar
• Age standardization of rates: A new WHO standard [Internet]. Available from: http://www.who.int/healthinfo/paper31.pdf.
   Google Scholar
• Whelan J, McTiernan A, Cooper N, Wong YK, Francis M, Vernon S, et al. Incidence and survival of malignant bone sarcomas in England 1979–2007. Int J Cancer 2012;131: E508–17.
   PubMed Web of Science ®Google Scholar
• Mirabello L, Troisi RJ, Savage SA. International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons. Int J Cancer 2009;125:229–34.
   PubMed Web of Science ®Google Scholar
• Mirabello L, Troisi RJ, Savage SA. Osteosarcoma incidence and survival rates from 1973 to 2004: Data from the surveillance, epidemiology, and end results program. Cancer 2009;115:1531–43.
   PubMed Web of Science ®Google Scholar
• Schwarz R, Bruland O, Cassoni A, Schomberg P, Bielack S. The role of radiotherapy in oseosarcoma. Cancer Treat Res 2009;152:147–64.
   PubMedGoogle Scholar
• Kotz R, Dominkus M, Zettl T, Ritschl P, Windhager R, Gadner H, et al. Advances in bone tumour treatment in 30 years with respect to survival and limb salvage. A single institution experience. Int Orthop 2002;26:197–202.
   PubMed Web of Science ®Google Scholar
• Wu PK, Chen WM, Chen CF, Lee OK, Haung CK, Chen TH. Primary osteogenic sarcoma with pulmonary metastasis: Clinical results and prognostic factors in 91 patients. Jpn J Clin Oncol 2009;39:514–22.
   PubMed Web of Science ®Google Scholar
• Bielack SS, Kempf-Bielack B, Branscheid D, Carrle D, Friedel G, Helmke K, et al. Second and subsequent recurrences of osteosarcoma: Presentation, treatment, and outcomes of 249 consecutive cooperative osteosarcoma study group patients. J Clin Oncol 2009;27:557–65.
   PubMed Web of Science ®Google Scholar
• Kempf-Bielack B, Bielack SS, Jurgens H, Branscheid D, Berdel WE, Exner GU, et al. Osteosarcoma relapse after combined modality therapy: An analysis of unselected patients in the cooperative osteosarcoma study group (COSS). J Clin Oncol 2005;23:559–68.
   PubMed Web of Science ®Google Scholar
• Okada K, Hasegawa T, Nishida J, Ogose A, Tajino T, Osanai T, et al. Osteosarcomas after the age of 50: A clinicopathologic study of 64 cases – an experience in northern Japan. Ann Surg Oncol 2004;11:998–1004.
   PubMed Web of Science ®Google Scholar
• Bacci G, Longhi A, Cesari M, Versari M, Bertoni F. Influence of local recurrence on survival in patients with extremity osteosarcoma treated with neoadjuvant chemotherapy: The experience of a single institution with 44 patients. Cancer 2006;106:2701–6.
   PubMed Web of Science ®Google Scholar
• Bispo Junior RZ, Camargo OP. Prognostic factors in the survival of patients diagnosed with primary non-metastatic osteosarcoma with a poor response to neoadjuvant chemotherapy. Clinics (Sao Paulo) 2009;64:1177–86.
   PubMed Web of Science ®Google Scholar
• Meyers PA, Schwartz CL, Krailo M, Kleinerman ES, Betcher D, Bernstein ML, et al. Osteosarcoma: A randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. J Clin Oncol 2005;23:2004–11.
   PubMed Web of Science ®Google Scholar
• Bacci G, Picci P, Ferrari S, Sangiorgi L, Zanone A, Brach del Prever A. Primary chemotherapy and delayed surgery for non-metastatic telangiectatic osteosarcoma of the extremities. Results in 28 patients. Eur J Cancer 1994;30A:620–6.
   PubMed Web of Science ®Google Scholar
• Bacci G, Ferrari S, Mercuri M, Longhi A, Fabbri N, Galletti S, et al. Neoadjuvant chemotherapy for osteosarcoma of the extremities in patients aged 41–60 years: Outcome in 34 cases treated with adriamycin, cisplatinum and ifosfamide between 1984 and 1999. Acta Orthop 2007; 78:377–84.
   PubMed Web of Science ®Google Scholar
• Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, Helmke K, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 2002;20:776–90.
   PubMed Web of Science ®Google Scholar
• Jeon DG, Lee SY, Cho WH, Song WS, Park JH. Primary osteosarcoma in patients older than 40 years of age. J Korean Med Sci 2006;21:715–8.
   PubMed Web of Science ®Google Scholar